JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITEDSET: JSP🇹🇭 TH
This company's most recent 56-1 One Report was filed as a PDF document (spec v3.0), so SET does not publish its section-by-section detail in a machine-readable form. Some information on this site is therefore incomplete.

Financial Information

Key Financial Highlights

As at 2026-06-30 · Unit: M.Baht

Item202320242025H1 2026
Total revenue594.36845.931,043446.49
Net profit-1.274.5267.8710.67
Total assets1,3361,3271,4641,439
Total liabilities405.17444.13536.56524.02
Shareholders' equity870.06858908.61894.02
EPS (Baht)-0.010.010.140.02
ROE (%)-0.140.527.684.8
ROA (%)3.95-1.268.216.35
Net profit margin (%)4.75-3.924.332.43
D/E (times)0.440.50.580.57
ItemY/E 2023Dec 2023Y/E 2024Dec 2024Y/E 2025Dec 20256M/2025Jun 20256M/2026Jun 2026
Cash And Cash Equivalents20.6529.4948.0337.2342.84
A/R Net122.63156.56178.19171.41158.1
Inventories102.15122.42101.44135.37120
Current Assets245.61313.66327.66349.16320.94
PP&E Net859.66905.471,071.78884.91,053.34
Non-Current Assets1,090.061,012.991,135.89994.151,118.46
Total Assets1,335.671,326.651,463.561,343.311,439.4
OD87.7156.8647.8448.4280.99
A/P Net75.0594.82101.07101.9192.75
Current portion of LT10.5328.0744.3517.3545.07
Current Liabilities194.8228.45236.54227.25252.06
Non-Current Liabilities210.38215.67300.02203.18271.96
Total Liabilities405.17444.13536.56430.43524.02
Authorized Capital341.25355.93355.93355.93355.93
Paid-Up Capital237.28237.29237.29237.29237.29
Premium (Discount) on Share Capital772.49772.53722.93722.93722.93
Retained Earnings (Deficit)-9.36-21.4770.7463.7558.92
Treasury Stock—————
Shares Of The Company Held By Subsidiaries—————
Other Components Of Equity-130.35-130.35-122.35-130.35-125.12
- Surplus (Deficits)-130.35-130.35-122.35-130.35-125.12
Shareholders' Equity870.06858908.61893.62894.02
Minority Interest60.4424.5218.3919.2621.36

Auditor's Reports

ReportDate of submissionAuditor’s opinionAuditor’s firm
Q2 /202611 Aug 2026Unqualified opinionPRICEWATERHOUSE COOPERS ABAS LIMITED
Q1 /202615 May 2026Unqualified opinionPRICEWATERHOUSE COOPERS ABAS LIMITED
Yearly 202527 Feb 2026Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED
Q3 /202512 Nov 2025Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED